<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03987022</url>
  </required_header>
  <id_info>
    <org_study_id>IRB18-00920</org_study_id>
    <nct_id>NCT03987022</nct_id>
  </id_info>
  <brief_title>ICE T for Post GYN Surgery Pain</brief_title>
  <official_title>&quot;ICE-T&quot; Postoperative Multimodal Pain Regimen Compared to the Standard Regimen in Laparoscopic Gynecologic Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MetroHealth Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized controlled trial is to determine whether, &quot;ICE-T,&quot; a
      multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and
      tylenol, has improved pain control compared to the standard narcotic based postoperative pain
      regimen in patients undergoing total laparoscopic gyn surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog pain (VAS) score</measure>
    <time_frame>Morning of post operative day 1 (~24 hours after surgery)</time_frame>
    <description>Visual Analog Scores (VAS) Scores in the morning of post op day 1 (~24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Scores</measure>
    <time_frame>VAS Scores at 4 and 12 hours post surgery</time_frame>
    <description>Visual Analog Scores at 4 and 12 hours post surgery. The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Total length of hospitalization in days</time_frame>
    <description>Length of hospital stay in number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of opioid</measure>
    <time_frame>Total opioid use up to post op day 4</time_frame>
    <description>Total amount of opioids in morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of urinary retention</measure>
    <time_frame>Up to post op day 4</time_frame>
    <description>Incidence of urinary retention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel movement</measure>
    <time_frame>Up to post op day 4</time_frame>
    <description>Time to first bowel movement in days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Opioid Substitution Treatment</condition>
  <arm_group>
    <arm_group_label>&quot;ICE-T&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regimen #1 &quot;ICE-T&quot; Opioid Sparing Regimen At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive
ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge.
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.
Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge
Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain.
Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regimen #2 STANDARD Postoperative Regimen
Once out of the PACU patients will receive &quot;Standard&quot; postoperative regimen
Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain
Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain
Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain
Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain.
Patients will be discharged home with Motrin and Percocet for pain PRN.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>Use of non-steroidal anti-inflammatory drug for pain control post operatively</description>
    <arm_group_label>&quot;ICE-T&quot;</arm_group_label>
    <other_name>Toradol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioids</intervention_name>
    <description>Use of narcotic for pain control post operatively</description>
    <arm_group_label>Standard of care</arm_group_label>
    <other_name>Oxycodone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ice Packs</intervention_name>
    <description>Placement of Ice packs on surgical sites post operatively</description>
    <arm_group_label>&quot;ICE-T&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tylenol</intervention_name>
    <description>Use of pain medication post operatively</description>
    <arm_group_label>&quot;ICE-T&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Motrin</intervention_name>
    <description>Use of non-steroidal anti-inflammatory drug for pain control post operatively</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dilaudid</intervention_name>
    <description>Use of narcotic for pain control post operatively</description>
    <arm_group_label>&quot;ICE-T&quot;</arm_group_label>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The inclusion criteria are the following:

          -  Consenting, English speaking women between ages 18 and 80 who will undergo same day
             laparoscopic gyn surgery at MetroHealth Medical Center

          -  Ability to read VAS Scores

          -  Specific procedures include, but are not limited to:

               -  Laparoscopic hysterectomy, for uterus 250 g or less

               -  Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s),
                  and/or ovary(s)

               -  Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s),
                  and/or ovary(s), with repair of enterocele

               -  Laparoscopic hysterectomy, for uterus 250 g or less; with repair of enterocele

               -  Laparoscopic hysterectomy, for uterus greater than 250 g

               -  Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s)
                  and/or ovary(s)

               -  Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s)
                  and/or ovary(s), with repair of enterocele

               -  Laparoscopic hysterectomy, for uterus greater than 250 g; with repair of
                  enterocele

        Exclusion Criteria:

          -  History of chronic pelvic pain

          -  Abdominal surgery

          -  History of psychiatric disease

          -  Currently taking analgesic medications

          -  Currently taking sedatives

          -  Liver disease

          -  Renal disease with CrCl &lt; 60cc/min.

          -  History of burns from application of ice.

          -  Women who did not consent for the study.

          -  Intraoperative concern for increased blood loss

          -  Unable to speak English

          -  Unable to understand VAS Scores

          -  Undergoing concomitant abdominal procedures.

          -  Allergy to motrin, toradol, Percocet, Tylenol

          -  Active or history of peptic ulcer disease

          -  History of GI bleeding or perforation

          -  Hemorrhagic diathesis

          -  Severe uncontrolled heart failure

          -  Inflammatory bowel disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Pollard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MetroHealth Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Darvish, MD</last_name>
    <phone>2167784444</phone>
    <email>rdarvish@metrohealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Pollard, MD</last_name>
    <phone>2167784444</phone>
    <email>rpollard@metrohealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Darvish, MD</last_name>
      <phone>216-778-4444</phone>
      <email>rdarvish@metrohealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.ajog.org/action/showCitFormats?pii=S0002-9378%2819%2930045-6&amp;doi=10.1016%2Fj.ajog.2019.01.017</url>
    <description>ICE-T postoperative multimodal pain regimen compared to the standard regimen in vaginal pelvic reconstructive surgery: a multicenter randomized controlled trial</description>
  </link>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 11, 2019</study_first_submitted>
  <study_first_submitted_qc>June 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2019</study_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MetroHealth Medical Center</investigator_affiliation>
    <investigator_full_name>Robert Pollard, MD</investigator_full_name>
    <investigator_title>Assistant Professor of Reproductive Biology</investigator_title>
  </responsible_party>
  <keyword>Anti-inflammatory agents non-steroidal</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

